Search results
Significant gaps between science of obesity and the care patients receive, say experts
Medical Xpress· 4 days ago"Obesity is undeniably a critical public health concern in the U.S. and around the world, affecting...
Wegovy could be treating more than obesity
Medical Xpress· 1 day agoA new analysis found that the profound benefits of Novo Nordisk's obesity drug Wegovy for people at risk of heart attacks or strokes don't depend on the...
Adding this 1 thing to primary care helped patients with obesity lose weight
Becker’s Hospital Review· 1 day agoInstead, they added a person to primary care visits, someone who is an expert in weight loss, and it worked, according to the study, which was published May 21 in JAMA. Researchers identified ...
Most people quit Wegovy, Saxenda before they see weight loss benefits
MedicalNewsToday via AOL· 1 day agoA report by Blue Shield notes that more than half of people on weight loss medications such as...
Weight-loss drugs help lift pharma's reputation
Axios· 1 day agoThe blockbuster success of new anti-obesity drugs helped boost the corporate reputations of pharmaceutical brands, according to new rankings from the annual ...
Exclusive | Eli Lilly to Spend $5.3 Billion to Make More Mounjaro, Zepbound
The Wall Street Journal· 1 hour agoThe outlay to expand an Indiana production site, combined with a previous $3.7 billion commitment,...
ENDO 2024 press conferences to highlight male birt | Newswise
Newswise· 3 days agoResearchers will delve into emerging research in diabetes, obesity, reproductive health and other aspects of hormone health during the Endocrine Society’s ENDO 2024 news conferences ...
Adding obesity experts to primary care clinics imp | Newswise
Newswise· 3 days agoGiving high-risk patients access to an obesity specialist through their regular primary care clinic increased their chances of receiving at least one evidence-based weight-management ...
Ozempic keeps wowing: trial data show benefits for kidney disease
Nature· 14 hours agoSemaglutide, the same compound in obesity drug Wegovy, slashes risk of kidney failure and death for...
Small Business - The Andalusia Star-News | The Andalusia Star-News
The Andalusia Star-News· 6 hours agoSTOCKHOLM, Sweden, May 24, 2024 (GLOBE NEWSWIRE) -- Atrogi, a pioneering clinical-stage biotech company advancing treatments for metabolic disorders, announces a publication in the Journal of Molecular Metabolism (1). The research paper validates
